Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · May 10, 2018

The Role of PARP Inhibition in TNBC

Cancer Treatment Reviews

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer Treatment Reviews
The Role of PARP Inhibition in Triple-Negative Breast Cancer: Unraveling the Wide Spectrum of Synthetic Lethality
Cancer Treat. Rev 2018 May 02;[EPub Ahead of Print], M Papadimitriou, G Mountzios, CA Papadimitriou

Further Reading